Morgan Stanley Downgrades Ironwood Pharmaceuticals (IRWD) to Equalweight
Morgan Stanley downgraded Ironwood Pharmaceuticals (NASDAQ: IRWD) from Overweight to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
